Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

This study has been completed.
Information provided by (Responsible Party):
Celator Pharmaceuticals Identifier:
First received: November 10, 2008
Last updated: May 16, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 16, 2012